Pages

Testimonials

Customers Testimonials – LRC-TriCEPS Service


Please see below the testimonials from our customers who have used  the LRC-TriCEPSTM technology (CaptiRec) in collaboration with Dualsystems Biotech AG.

The Rockefeller University



“We are very pleased with the work product of Dualsystems Biotech. The TriCEPS reagent allowed us to identify a novel ligand-extracellular matrix protein receptor interaction, which was not possible using traditional techniques. The Dualsystems team were very helpful in tailoring the experimental conditions to fit our biological question.”



Manish Ponda, M.D., M.S., Assistant Professor of Clinical Investigation
The Rockefeller University

Medizinische Hochschule Hannover



With the support of Dualsystems Biotech and their LRC-TriCEPS technology we were able to identify receptor candidates for our peptide with renoprotective properties in kidney injury.


mh-hannover-logo


Dr. rer. nat. Inga Sörensen-Zender, Postdoc
Medizinische Hochschule Hannover

Igenica Biotherapeutics



« Leveraging Dualsystems Biotech novel linker technology (LRC-TriCEPS) and its analytical data processing capabilities we were able to identify the heterophilic receptor for a highly-pursued immuno-oncology target.»


Igenica-Biotherapeutics-logo


Dr. Edward van der Horst,
Senior Director, Preclinical Development
Igenica Biotherapeutics

East Tennessee State University



Jonathan M Peterson, April 2016, The FASEB Journal, vol. 30 no. 1 Supplement 1249.2 Identification of cell surface receptors for the novel adipokine CTRP3

For the ligand sample two unique receptors were identified. Flow cytometry analysis with siRNA induced knockdown of these proteins confirmed that the presence of the protein is needed for CTRP3 binding to occur. CONCLUSION The LRC-TriCEPS methodology was successful in identifying the receptor for CTRP3.


Logo East Tennessee State University


Jonathan M Peterson
Assistant Professor
East Tennessee State University

CEDOC – Centro de Estudos de Doenças Crónicas


New publication October 2015 in Nature Communications using the LRC-TriCEPS technology in collaboration with Alisson M. Gontijo, Principal Investigator at CEDOC (Centro de Estudos de Doenças Crónicas)


« The fruitful collaboration with Dualsystems Biotech using the LRC-TriCEPS (CaptiRec) technology showed that even on insect cells receptors could be identified »


Cedoc-logo


Alisson M. Gontijo,
Principal Investigator at CEDOC
Centro de Estudos de Doenças Crónicas

University of California San Francisco (UCSF)


“We have been trying to identify a receptor that has been sought after for nearly 30 years by laboratories across the globe. Thanks to Dualsystems service CaptiRec (LRC-TriCEPS), we now have a strong candidate receptor.”


Logo University of Califonia SF


De’Broski R. Herbert Ph.D.
Assistant Professor in Residence
University of California San Francisco (UCSF)

Washington University School of Medicine


“Thanks to LRC-TriCEPS (CaptiRec) technology we were able to identify a long sought receptor of our ligand using genetically-engineered cell lines with the support of Dualsystems”


Logo Washington_University


Fumihiko Urano, MD, PhD
Samuel E. Schechter Professor of Medicine
Washington University School of Medicine